Searched for
RANBAXY PHARMACEUTICALS
NCLAT quashes Ligare Aviation's insolvency; loan from Religare Enterprises round-tripping of moneyThe National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...- Fortis liability case: Delhi HC says blame can't be shifted to third partyAmid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the S...
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Cipher, Ranbaxy settle patent litigation with ActavisCipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litiga...
- US Federal Trade Panel wraps up review of Sun Pharms's Ranbaxy acquisitionSun Pharmaceutical has moved closer to wrapping up its proposed acquisition of Ranbaxy Laboratories with the US Federal Trade Commission co...
- Minority shareholders approval not needed for Sun deal: RanbaxyOn April 7, Sun Pharmaceutical announced it will fully acquire the troubled Ranbaxy Laboratories in an all-stock transaction with a total e...
- Alembic Pharma gets USFDA nod for antidepressant tabletsAlembic Pharmaceuticals receives approval from the US health regulator for Desvenlafaxine base extended release tablets used for treating m...
- Ranbaxy launches generic version of Evoxac in US marketRanbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market.
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Ranbaxy gets USFDA nod for generic version of ulcer drugDrug maker Ranbaxy Laboratories today said it has received approval from the US drug regulator for manufacturing and marketing the generic ...
- Ranbaxy Labs receives USFDA for Cefuroxime AxetilRanbaxy Laboratories has received approval from the US Food and Drug Administration to manufacture and market Cefuroxime Axetil for Oral Su...
- Ranbaxy receives nod for Tamsulosin Hydrochloride capsules in CanadaRanbaxy Laboratories has received approval to manufacture and market Tamsulosin Hydrochloride capsules in 0.4 mg strength from Health Canad...
- Ranbaxy to invest $14 m in SA unitCompany got Johannesburg’s nod for Be-Tabs buyout last week.
- Ranbaxy to tap South African marketPharma major Ranbaxy Laboratories on Tuesday said the acquisition of Be-Tabs Pharmaceuticals (Pty) Ltd (Be-Tabs) has been further strengthe...
- Ranbaxy to market second licensed generic in CanadaThe generic fentanyl patch is sold under Ranbaxy's label 'Ran Fentanyl Transdermal System', used for management of persistent and chronic p...
- Ranbaxy ties up with Ipca LaboratoriesPharmaceutical major Ranbaxy on Thursday said it has entered into a strategic alliance with Mumbai-based Ipca Laboratories to develop gener...
- Ranbaxy ties up with US coPharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc.
Load More
